We examined effects of intravenous administration of glucagon-like peptide 1 (GLP-1) on growth hormone (GH) secretion in ruminants. Four Suffolk rams, aged 2 years, were fed at 16.00 h. They were bled every 5 min from 12.00 until 17.00 h. GLP-1(7-36)amide was intravenously infused at a rate of 1.2 pmol/kg/min from 12.00 to 17.00 h. GH peak frequency was signifi cantly (P<0.05) increased. GLP-1 did not affect GH peak amplitude. Plasma insulin levels transiently increased just after the start of GLP-1 infusion. Plasma glucose levels did not change. GLP-1 may be a physiological regulator of spontaneous pulsatile GH secretion in ruminants.
INTRODUCTION
Glucagon-like peptide 1 (GLP-1) is a peptide, which is secreted from the intestine into the circulation and enhances both insulin release (Schmidt et al., 1985) and synthesis (Drucker et al., 1987) . GLP-1 receptors have been found in the anterior pituitary (Alvarez et al., 1996) , whereas the role of GLP-1 on the secretion of anterior pituitary hormones has been scarcely examined. It has been reported that GLP-1 reduces GH responses during hypoglycaemia in humans (Nauck et al., 2002) . We examined effects of continuous administration of GLP-1 on plasma GH, insulin, and glucose levels in sheep.
MATERIAL AND METHODS
Four Suffolk rams, aged 2 years, were kept in metabolism crates in a controlled environmental room at 24°C under a 12-h light-dark cycle (07.30-19.30 h, light; 19.30-07.30 h, dark) . The rams were fed a suffi cient quantity of lucerne hay cubes to meet 120% of their daily metabolizable energy requirements at 16.00 h, and allowed free access to water throughout the experiment. The animals received right and left jugular catheters. At fi rst, the animals were subjected to saline infusion, and three days later, the same animals were subjected to GLP-1 infusion. Blood samples were collected from the right jugular venous at 5 min intervals from 12.00 until 17.00 h. Control animals were subjected to a continuous administration of 0.9% saline containing 0.1% ovine albumin at a rate of 1 ml/min. GLP-1(7-36)amide, dissolved in the saline, was infused into the left jugular venous at a rate of 1.2 pmol/kg/min over 5 h (from 12.00 to 17.00 h). Blood samples were immediately placed into heparinized tubes with aprotinin (5000 KIU/ml of blood) and centrifuged for 10 min at 4°C. Harvested plasma was stored at -80°C until assay. Plasma GH and insulin concentrations were measured by time-resolved fl uoro-immunoassay (TR-FIA). The blood glucose levels were determined by an automated glucose analyser on the basis of glucose oxidase reaction. The pulsatile patterns of GH secretions were analysed in individual animals using the PULSAR program.
RESULTS
GLP-1 produces modest increases in mean concentration and peak frequency of circulating GH (Figure 1 ). There was a marginally insignifi cant effect of GLP-1 treatment on mean GH (P=0.054), but a signifi cant effect on peak frequency EFFECT OF GLP-1 ON GH SECRETION IN SHEEP Figure 1 . Representative profi le of plasma GH and insulin levels in sheep treated with GLP-1 (P<0.05). GLP-1 did not affect GH peak amplitude. Plasma insulin concentrations were transiently increased just after the start of GLP-1 infusion (Figure 1 ). There was no treatment effect in plasma glucose levels.
DISCUSSION
The profi les of GH secretion were variable according to individuals. However the results of pulse analysis suggested that GLP-1 might infl uence pulsatile GH secretion. The stimulatory effect of GLP-1 on insulin secretion was temporal, suggesting that GLP-1 stimulates insulin release but does not enhance its synthesis in sheep. Accordingly, the stimulatory effects of GLP-1 on pulsatile GH secretion might not be due to the changes in circulating insulin levels. These results indicate that GLP-1 is a physiological regulator of spontaneous pulsatile GH secretion in ruminants.
